NEW YORK, NY
Allocation by class
Portfolio Concentration
Top 3 weight
59.6%
Top 10 weight
96.2%
Voting Authority Distribution
Total shares with voting rights: 53.60M
Full voting authority
50.48M
shares
Joint voting authority
3.12M
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ORIC PHARMACEUTICALS INCSOLE | COM | 4.78M | SH | $57.65M 24.14% | 4.78M | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 22.03M | SH | $49.79M 20.85% | 22.03M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 3.46M | SH | $34.92M 14.63% | 3.46M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 295.65K | SH | $31.35M 13.13% | 295.65K | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 2.84M | SH | $16.83M 7.05% | 2.84M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDDFND | SHS | 1.88M | SH | $11.93M 5.00% | 0.00 | 1.88M | 0.00 |
PYXIS ONCOLOGY INCSOLE | COMMON STOCK | 7.03M | SH | $9.21M 3.86% | 5.95M | 1.08M | 0.00 |
CARIBOU BIOSCIENCES INCSOLE | COM | 4.69M | SH | $8.35M 3.50% | 4.69M | 0.00 | 0.00 |
SPERO THERAPEUTICS INCSOLE | COM | 2.36M | SH | $5.50M 2.31% | 2.36M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 505.64K | SH | $4.23M 1.77% | 505.64K | 0.00 | 0.00 |
CARDIFF ONCOLOGY INCSOLE | COM | 2.41M | SH | $3.74M 1.57% | 2.41M | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 953.83K | SH | $2.00M 0.84% | 953.83K | 0.00 | 0.00 |
NEXTCURE INCSOLE | COM NEW | 153.35K | SH | $1.54M 0.64% | 25.79K | 127.57K | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | ADS | 75K | SH | $813.8K 0.34% | 75K | 0.00 | 0.00 |
Q32 BIO INCSOLE | COM | 101.62K | SH | $736.7K 0.31% | 101.62K | 0.00 | 0.00 |
BOLT BIOTHERAPEUTICS INCDFND | COM NEW | 31.30K | SH | $137.1K 0.06% | 0.00 | 31.30K | 0.00 |
GINKGO BIOWORKS HOLDINGS INCSOLE | CL A NEW | 2.93K | SH | $17.4K <0.01% | 247.00 | 2.68K | 0.00 |
SENSEONICS HLDGS INCDFND | COM | 2.17K | SH | $14.2K <0.01% | 0.00 | 2.17K | 0.00 |